Tilray Brands (TLRY) Accumulated Expenses (2017 - 2026)
Tilray Brands (TLRY) posted Accumulated Expenses of $70.3 million for Q1 2026, up 1265.6% on a QoQ basis from $5.2 million in Q4 2025, and up 2090.66% year-over-year from $3.2 million in Q1 2025.
Tilray Brands (TLRY) Accumulated Expenses (2017 - 2026) Analysis & Trends
Tilray Brands' Accumulated Expenses history runs 9 years deep, the most recent figure standing at $70.3 million for Q1 2026.
- Quarterly Accumulated Expenses rose 2090.66% year-over-year to $70.3 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $70.3 million (up 2090.66% YoY) and the FY2025 annual result came in at $4.2 million, down 95.46% from the prior year.
- Accumulated Expenses was $70.3 million for Q1 2026 at Tilray Brands, up from $5.2 million in the prior quarter.
- Across five years, Accumulated Expenses topped out at $92.4 million in Q2 2024 and bottomed at $2.7 million in Q3 2025.
- A 5-year average of $24.0 million and a median of $7.0 million in 2022 frame the typical range for Accumulated Expenses.
- Annual changes were most pronounced in 2025 — Accumulated Expenses sank 97.05% — and 2026, when it jumped 2090.66%.
- Tilray Brands' Accumulated Expenses stood at $7.3 million in 2022, then increased by 12.25% to $8.1 million in 2023, then tumbled by 36.65% to $5.2 million in 2024, then declined by 0.19% to $5.2 million in 2025, then jumped by 1265.6% to $70.3 million in 2026.
- Business Quant data shows TLRY's Accumulated Expenses at $70.3 million in Q1 2026, $5.2 million in Q4 2025, and $2.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Tilray Brands | 465.02 Mn | 373.06 Mn | 54.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 70.34 Mn |
| Nov 30, 2025 | 5.15 Mn |
| Aug 31, 2025 | 2.68 Mn |
| May 31, 2025 | 4.19 Mn |
| Feb 28, 2025 | 3.21 Mn |
| Nov 30, 2024 | 5.16 Mn |
| Aug 31, 2024 | 90.90 Mn |
| May 31, 2024 | 92.42 Mn |
| Feb 29, 2024 | 3.20 Mn |
| Nov 30, 2023 | 8.15 Mn |
| Aug 31, 2023 | 6.83 Mn |
| May 31, 2023 | 8.10 Mn |
| Feb 28, 2023 | 14.74 Mn |
| Nov 30, 2022 | 7.26 Mn |
| Aug 31, 2022 | 3.43 Mn |
| May 31, 2022 | 57.50 Mn |
| Mar 31, 2020 | 47.03 Mn |
| Dec 31, 2019 | 50.83 Mn |
| Sep 30, 2019 | 71.39 Mn |
| Mar 31, 2019 | 152.82 Mn |